Trademark Overview
On Tuesday, July 15, 2025, a trademark application was filed for THALASSA BIO with the United States Patent and Trademark Office. The USPTO has given the THALASSA BIO trademark a serial number of 99281882. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, July 15, 2025. This trademark is owned by FL2024-004, Inc.. The THALASSA BIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of muscle diseases and disorders, cardiac diseases and disorders, hematologic diseases and disorders, metabolic diseases and disorders, and central nervous system diseases and disorders; Biological preparations for the treatment of muscle diseases and disorders, cardiac diseases and disorders, hematologic diseases and disorders, metabolic diseases and disorders, and central nervous system diseases and disorders
Research and development services in the field of pharmaceutical preparations; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development services of new pharmaceutical products; Research and development in the field of pharmaceutical preparations for treating muscle diseases and disorders, cardiac diseases and disorders, hematologic diseases and disorders, metabolic diseases and disorders, and central nervous system diseases and disorders; Laboratory services for the production of pharmaceuticals in the nature of treatment for muscle diseases and disorders, cardiac diseases and disorders, hematologic diseases and disorders, metabolic diseases and disorders and central nervous system diseases and disorders